Exosome/microvesicle-mediated Epigenetic Reprogramming of Cells

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2011 Oct 5

PMID 21969178

Citations 237

Authors

Giovanni Camussi

Maria-Chiara Deregibus

Stefania Bruno

Cristina Grange

Valentina Fonsato

Ciro Tetta

Affiliations

Soon will be listed here.

Abstract

Microvesicles (MVs) are released by different cell types and may remain in the extracellular space in proximity of the cell of origin or may enter the biological fluids. MVs released by tumor cells are detectable in patients with cancer and their number in the circulation correlates with poor prognosis. Recent studies demonstrated that MVs may act as mediator of cell-to-cell communication thus ensuring short- and long-range exchange of information. Due to their pleyotropic effects, MVs may play a role in the prothrombotic state associated with cancer as well as in cancer development and progression. It has been recently shown that MVs may induce epigenetic changes in target cells by transferring genetic information. This finding suggests that tumor and stromal cells may talk each other via MVs to establish a favorable tumor niche and to promote tumor growth, invasiveness and progression. Moreover, MVs contain genetic material under the form of mRNA and microRNA, that may allow an easy screening for cancer genetic markers and offer new diagnostic and prognostic information. This review presents an overview of the many biological actions of MVs and of the potential role of MV-mediated exchange of genetic information among cells in tumor biology.

Citing Articles

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.

Miceli R, Chen T, Nose Y, Tichkule S, Brown B, Fullard J J Extracell Vesicles. 2024; 13(12):e70005.

PMID: 39625409 PMC: 11613500. DOI: 10.1002/jev2.70005.

Intercellular transfer of multidrug resistance mediated by extracellular vesicles.

Yang A, Sun H, Wang X Cancer Drug Resist. 2024; 7:36.

PMID: 39403600 PMC: 11472569. DOI: 10.20517/cdr.2024.84.

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury.

An J, Chen B, Zhang R, Tian D, Shi K, Zhang L Mol Neurobiol. 2024; 62(1):1291-1315.

PMID: 39312070 DOI: 10.1007/s12035-024-04490-0.

Large Extracellular Vesicles Derived from Natural Killer Cells Affect the Functions of Monocytes.

Sokolov D, Gorshkova A, Tyshchuk E, Grebenkina P, Zementova M, Kogan I Int J Mol Sci. 2024; 25(17).

PMID: 39273424 PMC: 11395174. DOI: 10.3390/ijms25179478.

The application potential of iMSCs and iMSC-EVs in diseases.

Zhou X, Liu J, Wu F, Mao J, Wang Y, Zhu J Front Bioeng Biotechnol. 2024; 12:1434465.

PMID: 39135947 PMC: 11317264. DOI: 10.3389/fbioe.2024.1434465.

References

Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L . Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007; 67(7):2912-5. DOI: 10.1158/0008-5472.CAN-07-0520. View

Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G . ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19(22):1875-85. PMC: 3150487. DOI: 10.1016/j.cub.2009.09.059. View

Herrera M, Fonsato V, Gatti S, Deregibus M, Sordi A, Cantarella D . Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 2009; 14(6B):1605-18. PMC: 3060338. DOI: 10.1111/j.1582-4934.2009.00860.x. View

Barry O, Kazanietz M, Pratico D, FitzGerald G . Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem. 1999; 274(11):7545-56. DOI: 10.1074/jbc.274.11.7545. View

van Doormaal F, KleinJan A, Di Nisio M, Buller H, Nieuwland R . Cell-derived microvesicles and cancer. Neth J Med. 2009; 67(7):266-73. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson P, Cihak J . Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000; 6(7):769-75. DOI: 10.1038/77498. View

de Palma M, Venneri M, Galli R, Sergi Sergi L, Politi L, Sampaolesi M . Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005; 8(3):211-26. DOI: 10.1016/j.ccr.2005.08.002. View

Kosaka N, Iguchi H, Ochiya T . Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101(10):2087-92. PMC: 11159200. DOI: 10.1111/j.1349-7006.2010.01650.x. View

10.

Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner A . Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood. 2001; 98(10):3143-9. DOI: 10.1182/blood.v98.10.3143. View

11.

Collino F, Deregibus M, Bruno S, Sterpone L, Aghemo G, Viltono L . Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010; 5(7):e11803. PMC: 2910725. DOI: 10.1371/journal.pone.0011803. View

12.

Barry O, Pratico D, Lawson J, FitzGerald G . Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997; 99(9):2118-27. PMC: 508042. DOI: 10.1172/JCI119385. View

13.

Yuan A, Farber E, Rapoport A, Tejada D, Deniskin R, Akhmedov N . Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One. 2009; 4(3):e4722. PMC: 2648987. DOI: 10.1371/journal.pone.0004722. View

14.

Al-Nedawi K, Meehan B, Kerbel R, Allison A, Rak J . Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009; 106(10):3794-9. PMC: 2656159. DOI: 10.1073/pnas.0804543106. View

15.

Losche W, Scholz T, Temmler U, Oberle V, Claus R . Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets. 2004; 15(2):109-15. DOI: 10.1080/09537100310001649885. View

16.

Hugel B, Martinez M, Kunzelmann C, Freyssinet J . Membrane microparticles: two sides of the coin. Physiology (Bethesda). 2005; 20:22-7. DOI: 10.1152/physiol.00029.2004. View

17.

Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M . Cells release prions in association with exosomes. Proc Natl Acad Sci U S A. 2004; 101(26):9683-8. PMC: 470735. DOI: 10.1073/pnas.0308413101. View

18.

Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler M, Zoeller M . CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med. 2008; 8(8):784-804. DOI: 10.2174/156652408786733667. View

19.

Orozco A, Lewis D . Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010; 77(6):502-14. PMC: 2919894. DOI: 10.1002/cyto.a.20886. View

20.

Peters B, Diaz L, Polyak K, Meszler L, Romans K, Guinan E . Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005; 11(3):261-2. DOI: 10.1038/nm1200. View